Blinding in randomized clinical trials: Imposed impartiality

Clinical Pharmacology and Therapeutics

Volumn 90, Issue 5, 2011, Pages 732-736

  Hrobjartsson A ^a   Boutron, I ^b,c  

^a Rigshospitalet   (Denmark)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CONCEPTUAL FRAMEWORK; DOUBLE BLIND PROCEDURE; EMPIRICAL RESEARCH; HEALTH CARE PERSONNEL; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE BLIND PROCEDURE; SYSTEMATIC ERROR; TRIPLE BLIND PROCEDURE; XEROSTOMIA;

BIAS (EPIDEMIOLOGY); DOUBLE-BLIND METHOD; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; SINGLE-BLIND METHOD; TERMINOLOGY AS TOPIC;

EID: 80054999745     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.207     Document Type: Article

References (39)

1. Streptomycin in pulmonary tuberculosis. Br. Med. J. 2(4582), 790-791 (1948).
2. Kaptchuk, T.J. Intentional ignorance: a history of blind assessment and placebo controls in medicine. Bull. Hist. Med. 72, 389-433 (1998). (Pubitemid 128461770)
3. Devereaux, P.J. et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 285, 2000-2003 (2001). (Pubitemid 32366954)
4. Haahr, M.T. & Hróbjartsson, A. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors. Clin. Trials 3, 360-365 (2006). (Pubitemid 44645826)
5. Devereaux, P.J. et al. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J. Clin. Epidemiol. 57, 1232-1236 (2004). (Pubitemid 40023142)
6. Hróbjartsson, A., Pildal, J., Chan, A.W., Haahr, M.T., Altman, D.G. & Gøtzsche, P.C. Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory. J. Clin. Epidemiol. 62, 967-973 (2009).
7. Schulz, K.F., Altman, D.G. & Moher, D.; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 7, e1000251 (2010).
8. Shipton, D., Tappin, D.M., Vadiveloo, T., Crossley, J.A., Aitken, D.A. & Chalmers, J. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ 339, b4347 (2009).
9. Spanos, N.P., Burgess, C.A., Cross, P.A. & MacLeod, G. Hypnosis, reporting bias, and suggested negative hallucinations. J. Abnorm. Psychol. 101, 192-199 (1992).
10. Hróbjartsson, A. & Gøtzsche, P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N. Engl. J. Med. 344, 1594-1602 (2001). (Pubitemid 32479913)
11. Hróbjartsson, A. & Gøtzsche, P.C. Placebo interventions for all clinical conditions. Cochrane Database Syst. Rev. CD003974 (2010).
12. Linde, K. et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293, 2118-2125 (2005). (Pubitemid 40617064)
13. Wager, T.D. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303, 1162-1167 (2004). (Pubitemid 38233575)
14. Psaty, B.M. & Prentice, R.L. Minimizing bias in randomized trials: the importance of blinding. JAMA 304, 793-794 (2010).
15. Guyatt, G.H. et al. Effect of encouragement on walking test performance. Thorax 39, 818-822 (1984). (Pubitemid 14022730)
16. Noseworthy, J.H., Ebers, G.C., Vandervoort, M.K., Farquhar, R.E., Yetisir, E. & Roberts, R. The impact of blinding on the results of a randomized, placebocontrolled multiple sclerosis clinical trial. Neurology 44, 16-20 (1994). (Pubitemid 24029420)
17. Pildal, J., Hróbjartsson, A., Jørgensen, K.J., Hilden, J., Altman, D.G. & Gøtzsche, P.C. Impact of allocation concealment on conclusions drawn from metaanalyses of randomized trials. Int. J. Epidemiol. 36, 847-857 (2007). (Pubitemid 47394153)
18. Wood, L. et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: metaepidemiological study. BMJ 336, 601-605 (2008). (Pubitemid 351439518)
19. Cohen J. Statistical Power Analysis for the Behavioral Sciences (Academic Press, New York, 1977).
20. Burkhoff, D. et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet 354, 885-890 (1999). (Pubitemid 29424017)
21. Oesterle, S.N. et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet 356, 1705-1710 (2000).
22. Walter, S.D., Awasthi, S. & Jeyaseelan, L. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example. Contemp. Clin. Trials 26, 459-468 (2005). (Pubitemid 41073674)
23. Boutron, I. et al. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review. PLoS Med. 3, e425 (2006).
24. Boutron, I., Guittet, L., Estellat, C., Moher, D., Hróbjartsson, A. & Ravaud, P. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 4, e61 (2007).
25. Cordonnier, C. et al.; GREFIG Study Group. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann. Intern. Med. 139, 8-18 (2003).
26. Francis, C.W. et al.; EXULT A Study Group. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N. Engl. J. Med. 349, 1703-1712 (2003). (Pubitemid 37315007)
27. Desbiens, N.A. Lessons learned from attempts to establish the blind in placebo-controlled trials of zinc for the common cold. Ann. Intern. Med. 133, 302-303 (2000). (Pubitemid 30660303)
28. Farr, B.M. & Gwaltney, J.M. Jr. The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold. J. Chronic Dis. 40, 875-879 (1987). (Pubitemid 17103679)
29. Brent, D. et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 299, 901-913 (2008). (Pubitemid 351397065)
30. Kolahi, J., Bang, H. & Park, J. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. Community Dent. Oral Epidemiol. 37, 477-484 (2009).
31. Sackett, D.L. Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't? Int. J. Epidemiol. 36, 664-665 (2007). (Pubitemid 47244572)
32. Fergusson, D., Glass, K.C., Waring, D. & Shapiro, S. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ 328, 432 (2004).
33. Boutron, I., Guittet, L., Estellat, C., Moher, D., Hróbjartsson, A. & Ravaud, P. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 4(2), e61 (2007).
34. Hróbjartsson, A., Forfang, E., Haahr, M.T., Als-Nielsen, B. & Brorson, S. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. Int. J. Epidemiol. 36, 654-663 (2007). (Pubitemid 47244571)
35. Sackett D.L. Testing for blindness at the end of your trial is a mug's game. Clin. Trials, in press.
36. McRae, C. et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch. Gen. Psychiatry 61, 412-420 (2004). (Pubitemid 38451551)
37. Schulz, K.F. & Grimes, D.A. Blinding in randomised trials: hiding who got what. Lancet 359, 696-700 (2002). (Pubitemid 34203775)
38. Chan, A.W., Hróbjartsson, A., Haahr, M.T., Gøtzsche, P.C. & Altman, D.G. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291, 2457-2465 (2004). (Pubitemid 38669189)
39. Meinert, C.L. Masked monitoring in clinical trials-blind stupidity? N. Engl. J. Med. 338, 1381-1382 (1998). (Pubitemid 28216671)